AIDS vaccine is about to be put first in humans

We hope you're about to see how it changes the history of this terrible deadly virus, the vaccine has been developed in the last 15 years by Robert Gallo, the scientist who demostróen 1984 HIV triggered the disease. Phase I of the implicará60 test volunteers and simplementepondrá proof security andthe immune response to the vaccine, so we will not know for sure for a while if it will be really effective comparison of otras100 + AIDS vaccines have been tested in the last 30 years. So far there have been extensive testing in monkeys to positive conresultados. They had done some candidatasprometedoras vaccines in the past, but the challenge of AIDS is that HIV directly infects white blood cells called T cells, which literally causes our immune system is against us. And once the virus has entered a T cell, it is invisible to the immune system. The only chance we have to prevent infection would be triggering antibodies against proteins of HIV, before we attack, how difficult is the fact that the retrovirus can periodically change to hide their viral envelope proteins on the surface of the cell. Gallo and his team of scientists from the Institute of Human Virology in the US, say Fumes may be found when the protein on the surface of HIV, known as gp120, is vulnerable to detection (the time the virus binds to T cells in our body). When HIV infects a patient, the first link reaches the CD4 receptor found on white blood cells. The transition then exposes hidden parts of the viral envelope, allowing them to join a second receptor called CCR5. Once HIV binds to these two receptors of T cells, successfully infects immune cell. And at that point, it's too late to stop. The vaccine known as "single chain length" contains the gp120 protein of HIV surface, designed to link a few portions of the CD4 receptor. The aim is to trigger gp120 antibodies when it is already bound to CD4 and is in its vulnerable state of transition. Profectus BioSciences, a biotechnology and the Institute of Human Virology Gallo, explaining who have taken the time to get to this point because they have been very careful in testing in monkeys, as well as financing the development of the drug human vaccine quality.